![Target 2035 – an update on private sector contributions - RSC Medicinal Chemistry (RSC Publishing) DOI:10.1039/D2MD00441K Target 2035 – an update on private sector contributions - RSC Medicinal Chemistry (RSC Publishing) DOI:10.1039/D2MD00441K](https://pubs.rsc.org/image/article/2023/MD/d2md00441k/d2md00441k-f2_hi-res.gif)
Target 2035 – an update on private sector contributions - RSC Medicinal Chemistry (RSC Publishing) DOI:10.1039/D2MD00441K
![SGC epigenetic probe distribution by year of approval and target class... | Download Scientific Diagram SGC epigenetic probe distribution by year of approval and target class... | Download Scientific Diagram](https://www.researchgate.net/publication/282156187/figure/fig2/AS:667945533444102@1536262033397/SGC-epigenetic-probe-distribution-by-year-of-approval-and-target-class-SGC-probes-meet_Q320.jpg)
SGC epigenetic probe distribution by year of approval and target class... | Download Scientific Diagram
![Deep Annotation of Donated Chemical Probes (DCP) in Organotypic Human Liver Cultures and Patient-Derived Organoids from Tumor and Normal Colorectum | ACS Chemical Biology Deep Annotation of Donated Chemical Probes (DCP) in Organotypic Human Liver Cultures and Patient-Derived Organoids from Tumor and Normal Colorectum | ACS Chemical Biology](https://pubs.acs.org/cms/10.1021/acschembio.2c00877/asset/images/medium/cb2c00877_0008.gif)
Deep Annotation of Donated Chemical Probes (DCP) in Organotypic Human Liver Cultures and Patient-Derived Organoids from Tumor and Normal Colorectum | ACS Chemical Biology
Combinatorial Anticancer Drug Screen Identifies Off-Target Effects of Epigenetic Chemical Probes | ACS Chemical Biology
![Development of SGC-GAK-1 as an orally active in vivo probe for cyclin G associated kinase through cytochrome P450 inhibition | bioRxiv Development of SGC-GAK-1 as an orally active in vivo probe for cyclin G associated kinase through cytochrome P450 inhibition | bioRxiv](https://www.biorxiv.org/content/biorxiv/early/2019/05/07/629220/F1.large.jpg)
Development of SGC-GAK-1 as an orally active in vivo probe for cyclin G associated kinase through cytochrome P450 inhibition | bioRxiv
![SGC-CK2-1: The First Selective Chemical Probe for the Pleiotropic Kinase CK2 | Organic Chemistry | ChemRxiv | Cambridge Open Engage SGC-CK2-1: The First Selective Chemical Probe for the Pleiotropic Kinase CK2 | Organic Chemistry | ChemRxiv | Cambridge Open Engage](https://chemrxiv.org/engage/api-gateway/chemrxiv/assets/orp/resource/item/60c74b3bee301cec6ac79dcd/largeThumb/sgc-ck2-1-the-first-selective-chemical-probe-for-the-pleiotropic-kinase-ck2.jpg)
SGC-CK2-1: The First Selective Chemical Probe for the Pleiotropic Kinase CK2 | Organic Chemistry | ChemRxiv | Cambridge Open Engage
![BAY-474, a SGC Epigenetic Probe, is a Tyrosine-Protein Kinase c-Met Inhibitor - Network of Cancer Research BAY-474, a SGC Epigenetic Probe, is a Tyrosine-Protein Kinase c-Met Inhibitor - Network of Cancer Research](https://www.cancer-research-network.com/wp-content/uploads/BAY-474-a-SGC-Epigenetic-Probe-is-a-Tyrosine-Protein-Kinase-c-Met-Inhibitor-2020-02-02.jpg)